Method for the diagnosis or prognosis, in vitro, of prostate cancer
US11459605B2 · kind B2 · utility
0Cited by
1References
18Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Dec 18, 2012 |
| Grant date | Oct 4, 2022 |
| Priority date | — |
| Expiry date | Nov 8, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12Q2600/158
- WIPO fieldMeasurement
- WIPO sectorInstruments
Abstract
The present invention relates to a method for the in vitro diagnosis or prognosis of prostate cancer, which includes a step of detecting at least one expression product of at least one HERV nucleic acid sequence, the use of said nucleic acid sequences, once isolated, as one or more molecular marker(s) and a kit comprising at least one specific binding partner of at least one of the expression products of the HERV nucleic acid sequences.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.